-
EP2906296
European procedure
Extract from the Register of European Patents
EP About this file: EP2906296
| EP2906296 - PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 25.01.2019 Database last updated on 05.05.2025 | |
| Former | The patent has been granted Status updated on 16.02.2018 | ||
| Former | Grant of patent is intended Status updated on 18.10.2017 | Most recent event Tooltip | 25.01.2019 | No opposition filed within time limit | published on 27.02.2019 [2019/09] | Applicant(s) | For all designated states ADC Therapeutics SA Route de la Corniche 3B 1066 Epalinges / CH | For all designated states Medimmune Limited Milstein Building Granta Park Cambridge, Cambridgeshire CB21 6GH / GB | [2018/12] |
| Former [2017/11] | For all designated states ADC Therapeutics SA route de la Corniche 3B 1066 Epalinges / CH | ||
| For all designated states Medimmune Limited Milstein Building Granta Park Cambridge, Cambridgeshire CB21 6GH / GB | |||
| Former [2015/34] | For all designated states ADC Therapeutics S.a.r.l. Rue Saint-Pierre 2 1003 Lausanne / CH | ||
| For all designated states Medimmune Limited Milstein Building Granta Park Cambridge, Cambridgeshire CB21 6GH / GB | Inventor(s) | 01 /
VAN BERKEL, Patricius Hendrikus Cornelis ADC Therapeutics Sàrl c/o Michael Forer Rue Saint-Pierre 2 1003 Lausanne / CH | 02 /
HOWARD, Philip Wilson Spirogen Limited The QMB Innovation Centre 42 New Road London Greater London E1 2AX / GB | [2015/34] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [N/P] |
| Former [2015/34] | Watson, Robert James, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | Application number, filing date | 13785373.5 | 11.10.2013 | [2015/34] | WO2013EP71349 | Priority number, date | US201261712924P | 12.10.2012 Original published format: US 201261712924 P | US201261712928P | 12.10.2012 Original published format: US 201261712928 P | US201361798106P | 15.03.2013 Original published format: US 201361798106 P | US201361798037P | 15.03.2013 Original published format: US 201361798037 P | US201361798072P | 15.03.2013 Original published format: US 201361798072 P | [2015/34] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014057119 | Date: | 17.04.2014 | Language: | EN | [2014/16] | Type: | A1 Application with search report | No.: | EP2906296 | Date: | 19.08.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 17.04.2014 takes the place of the publication of the European patent application. | [2015/34] | Type: | B1 Patent specification | No.: | EP2906296 | Date: | 21.03.2018 | Language: | EN | [2018/12] | Search report(s) | International search report - published on: | EP | 17.04.2014 | Classification | IPC: | A61K47/50, A61K45/06, A61K31/5517, C07K16/28, A61P39/00, A61P35/00 | [2017/19] | CPC: |
A61K47/6849 (EP,US);
A61K31/5517 (EP,US);
A61K45/06 (US);
A61K47/68035 (EP,US);
A61P35/00 (EP);
A61P39/00 (EP);
|
| Former IPC [2015/34] | A61P39/00, A61K47/48, A61P35/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/34] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | PYRROLOBENZODIAZEPIN-ANTIKÖRPER-KONJUGATE | [2015/34] | English: | PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES | [2015/34] | French: | CONJUGUÉS ANTICORPS - PYRROLOBENZODIAZÉPINE | [2015/34] | Entry into regional phase | 06.05.2015 | National basic fee paid | 06.05.2015 | Designation fee(s) paid | 06.05.2015 | Examination fee paid | Examination procedure | 06.05.2015 | Amendment by applicant (claims and/or description) | 06.05.2015 | Examination requested [2015/34] | 08.06.2016 | Despatch of a communication from the examining division (Time limit: M04) | 10.10.2016 | Reply to a communication from the examining division | 19.10.2017 | Communication of intention to grant the patent | 02.02.2018 | Receipt of the translation of the claim(s) | 05.02.2018 | Fee for grant paid | 05.02.2018 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 08.06.2016 | Opposition(s) | 02.01.2019 | No opposition filed within time limit [2019/09] | Fees paid | Renewal fee | 26.10.2015 | Renewal fee patent year 03 | 24.10.2016 | Renewal fee patent year 04 | 25.10.2017 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2008087184 (SERONO LAB [CH], et al); | [A]US2010203007 (LI WEI [US], et al); | [A]WO2012112687 (IMMUNOGEN INC [US], et al); | by applicant | JPS58180487 | US4816567 | US5583024 | US5621002 | US5674713 | US5700670 | WO9813059 | WO0012507 | US6214345 | US6218519 | US6268488 | WO02088172 | WO03026577 | US2003096743 | WO03043583 | US2003130189 | US6602677 | US6677435 | US2004018194 | US2004052793 | WO2004032828 | WO2004045512 | US2004121940 | US6759509 | US6835807 | WO2005079479 | WO2005082023 | US2005271615 | US2006116422 | WO2007044515 | US7223837 | WO2007085930 | US7375078 | US2008206239 | US7521541 | WO2009052249 | WO2010043380 | WO2010043880 | US7723485 | WO2011130613 | WO2011130616 | WO2011130598 | WO2011130615 |